医学理论与实践
醫學理論與實踐
의학이론여실천
The Journal of Medical Theory and Practice
2014年
20期
2661-2662,2671
,共3页
谭启明%刘锦屏%秦良光%于波%陈洪晔
譚啟明%劉錦屏%秦良光%于波%陳洪曄
담계명%류금병%진량광%우파%진홍엽
机械瓣膜置换术%抗凝%华法林
機械瓣膜置換術%抗凝%華法林
궤계판막치환술%항응%화법림
Mechanical valve replacement%Anticoagulant%Warfarin
目的:建立连云港地区心脏机械瓣膜置换术后早期华法林抗凝模型。方法:收集我院2010年9月-2013年9月心脏机械瓣膜置换手术采用华法林抗凝的患者,随机分为两组,起始剂量3.75mg组(A组)和起始剂量5mg组(B组),进行对比研究。比较两组抗凝起始剂量、维持剂量、抗凝强度、术后到达抗凝达标时间、抗凝稳定时间、术后抗凝并发症等。结果:A、B组抗凝模型均取得良好的抗凝结果;相比而言,B组模型比A组模型更有利于抗凝达标和稳定,抗凝并发症发生率比较无明显差别。结论:建立心脏机械瓣膜置换术后早期华法林抗凝模型,降低抗凝并发症发生率,从而降低医疗费用,改善患者长期生活质量。
目的:建立連雲港地區心髒機械瓣膜置換術後早期華法林抗凝模型。方法:收集我院2010年9月-2013年9月心髒機械瓣膜置換手術採用華法林抗凝的患者,隨機分為兩組,起始劑量3.75mg組(A組)和起始劑量5mg組(B組),進行對比研究。比較兩組抗凝起始劑量、維持劑量、抗凝彊度、術後到達抗凝達標時間、抗凝穩定時間、術後抗凝併髮癥等。結果:A、B組抗凝模型均取得良好的抗凝結果;相比而言,B組模型比A組模型更有利于抗凝達標和穩定,抗凝併髮癥髮生率比較無明顯差彆。結論:建立心髒機械瓣膜置換術後早期華法林抗凝模型,降低抗凝併髮癥髮生率,從而降低醫療費用,改善患者長期生活質量。
목적:건립련운항지구심장궤계판막치환술후조기화법림항응모형。방법:수집아원2010년9월-2013년9월심장궤계판막치환수술채용화법림항응적환자,수궤분위량조,기시제량3.75mg조(A조)화기시제량5mg조(B조),진행대비연구。비교량조항응기시제량、유지제량、항응강도、술후도체항응체표시간、항응은정시간、술후항응병발증등。결과:A、B조항응모형균취득량호적항응결과;상비이언,B조모형비A조모형경유리우항응체표화은정,항응병발증발생솔비교무명현차별。결론:건립심장궤계판막치환술후조기화법림항응모형,강저항응병발증발생솔,종이강저의료비용,개선환자장기생활질량。
Established early in Lianyungang warfarin model mechanical heart valve replacement surgery . Methods:Collected in our hospital in September 2010 to September 2013 mechanical heart valve replacement surgery pa-tients using warfarin were randomly divided into two groups ,the starting dose of 3 .75mg group (A) and the starting dose of 5mg group (group B) ,comparative study .Starting dose anticoagulation were compared ,the maintenance dose , anticoagulation intensity ,postoperative anticoagulation reach compliance time ,stable anticoagulation ,postoperative anti-coagulation complications .Results:A ,B group anticoagulant models have achieved good results anticoagulation;con-trast ,group B than in group A model anticoagulant standard model and more conducive to stable anticoagulation was no significant difference in the incidence of complications .Conclusion:A ,B group anticoagulant models have achieved good results anticoagulation;contrast ,group B than in group A model anticoagulant standard model and more conducive to stable anticoagulation was no significant difference in the incidence of complications .